Highlights and Quick Summary
- Financing cash flow for the quarter ending February 28, 2022 was $4.74 Million (a -2348.31% decrease compared to previous quarter)
- Year-over-year quarterly Financing cash flow decreased by -96.46%
- Annual Financing cash flow for 2021 was $140 Million (a 11.84% increase from previous year)
- Annual Financing cash flow for 2020 was $126 Million (a 105.25% increase from previous year)
- Annual Financing cash flow for 2019 was $61.1 Million (a -52.72% decrease from previous year)
- Twelve month Financing cash flow ending February 28, 2022 was $139 Million (a 47.15% increase compared to previous quarter)
- Twelve month trailing Financing cash flow decreased by -22.95% year-over-year
Trailing Financing cash flow for the last four month:
| 28 Feb '22 | 30 Nov '21 | 31 Aug '21 | 31 May '21 |
|---|---|---|---|
| $139 Million | $94.2 Million | $142 Million | $180 Million |
Visit stockrow.com/OGI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Financing cash flow of Organigram Holdings Inc.
Most recent Financing cash flowof OGI including historical data for past 10 years.Interactive Chart of Financing cash flow of Organigram Holdings Inc.
Organigram Holdings Inc. Financing cash flow for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | $4.74 | – | – | – | – |
| 2021 | $-0.21 | $0.04 | $134.01 | $-39.66 | $140.37 |
| 2020 | $48.0 | $37.51 | $16.05 | $39.99 | $125.5 |
| 2019 | $25.74 | $7.01 | $36.37 | $2.04 | $61.15 |
| 2018 | – | – | $10.64 | $128.36 | $129.32 |
| 2017 | – | – | – | – | $32.34 |
| 2016 | – | – | – | – | $28.81 |
Business Profile of Organigram Holdings Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic